europabio-logoeuropabio-logoeuropabio-logoeuropabio-logo
  • About us
    • Who we are
      • Governance
      • Staff
      • Vacancies
    • What we do
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Cell & Gene Therapies
      • Medicines For Rare Diseases And Children
      • Regulatory Efficiency
      • Biosimilars & Public Procurement
      • Data & Digital
      • Patient Bio-Forum
    • Industrial Biotechnology Council
      • Food, Feed & Nutrition
      • Circular Bioeconomy
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
  • Activities
    • 25 Years of Innovation
    • EFIB 2022
    • European Biotech Week
  • Events
  • Newsroom
    • News & Publications
    • Newsletter
    • Library
Become a member
✕

2000: Provitamin A enriched “Golden Rice” to combat vitamin A deficiency and blindness

16/06/2021

Nominated by: Scienceindustries Switzerland 

Organisation in nomination: Swiss Federal Institute of Technology, University of Freiburg   

In 2000, the research teams of Ingo Potrykus (Swiss Federal Institute of Technology, Zurich, Switzerland) and Peter Beyer (University of Freiburg, Germany) published their ground-breaking proof-of-concept paper describing genetically modified rice with provitamin A enriched endosperm. The aim was to combat vitamin A deficiency, that causes a quarter of a million cases of blindness in Southeast Asian children and a million deaths globally due to malnutrition. Rice with increased provitamin A content could be an easy and cost-efficient solution to supplement diets, especially in countries where rice is a predominant staple food.

An improved version “Golden Rice 2” with further increased provitamin A content was developed by Syngenta scientists and published in 2005. It had potential to supply an important part of the human daily vitamin A need. Conditions were established where this rice could be distributed to smallholder farmers free of licensing fees. From the beginning, the project met fierce opposition from technology-critical NGOs that resulted in high legal hurdles and long delays of the authorization process. After more than two decades, Golden Rice now is now close to cultivation authorization in the Philippines and in Bangladesh following to successful field trials.

In 2018, first approvals as food were granted in Australia, New Zealand, Canada and the US.  In 2019, it was approved for direct use as human food and animal feed or for processing in the Philippines.

References:

  • Xudong Ye et al. 2000, Engineering the Provitamin A (β-Carotene) Biosynthetic Pathway into (Carotenoid-Free) Rice Endosperm, Science 287:303-305
  • This Rice Could Save a Million Kids a Year, Time Magazine, July 31, 2000
  • Jacqueline A Paine et al. 2005, Improving the nutritional value of Golden Rice through increased pro-vitamin A content, Nature Biotechnology 23:482–487
  • Adrian Dubock 2019, Golden Rice: To Combat Vitamin A Deficiency for Public Health,”Vitamin A”, IntechOpen (book chapter)
  • Mallikarjuna Swamy 2021, Development and characterization of GR2E Golden rice, introgression lines, Scientific Reports 11:2496

Back to the list.

Share
Alexandra Simionca
Alexandra Simionca
EuropaBio-Logo-White

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 2600 biotech companies, 2300 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2023 Europabio. All Rights Reserved. Designed by EYAS
Become a member
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkLegal & Cookies